May 21, 2013
Wright & Filippis Exits Diabetes Market
Wright & Filippis, a Michigan-based home medical equipment provider, has announced that it will be exiting the diabetes market. The company has entered into an agreement to sell its diabetic supply business to US MED, another home medical equipment provider.
Share This Story
HME News Staff
ROCHESTER HILLS, Mich. – Wright & Filippis announced today that it has entered into an agreement to divest its diabetic supply business to US MED.
The reason: The company did not receive a contract to provide diabetes supplies as part of a national mail-order program that will go into effect July 1. US MED, along with 17 others, did receive a contract.
“Because of this change, we decided it was an appropriate time to sell our diabetes supply business to US MED,” stated AJ Filippis, president of Wright & Filippis, in a press release.
Due to the divestiture, Wright & Filippis will reduce its workforce by 3% over a 60-day period, according to the release. The company operates 35 locations and employs more than 900.
Wright & Filippis will now focus on its “traditional strengths” of orthotics and prosthetics, Filippis stated. Earlier this year, the company bought a controlling share of Carolina Orthotics & Prosthetics in North Charleston, S.C.
For its part, US MED may not be happy with the results of the mail-order program, but it’s committed to serving Wright & Filippis’ customers “with superior customer service,” stated CEO Zachary Schiffman in the release.
US MED is one of the largest providers of testing strips to Medicare beneficiaries in the nation. In 2011, the company received $25.7 million for strips, behind only Liberty Medical, DEGC Enterprises and Diabetes Care Club, according to data obtained from CMS and featured in the HME Databank.
Disclaimer
This content is for informational purposes only and is not a substitute for medical advice. Check with your healthcare provider before making changes to your health routine.
Latest Media
Finding a Trusted DME for Optimal Diabetes Care
Empowering Diabetes Patients by Shirley DeLeon Friday, January 10, 2025 Affecting more than 537 million people worldwide, diabetes is the fastest-growing chronic disease in the world. More than 38 million Americans have the disease, and researchers believe that number will increase by 54% by 2030. The health care landscape is changing to meet the demands…
ADS TAKES ON BURDEN FOR PHARMACIES
Theresa Flaherty, Managing Editor Updated 11:45 AM CDT, Fri July 19, 2024 CARLSBAD, Calif. – Advanced Diabetes Supply recently expanded its Part B services to retail pharmacies to include management of diabetes supplies. The move made sense for ADS, which has already been partnering with pharmacies to offer continuous glucose monitors, says CEO Bill Mixon….
How Advanced Diabetes Supply is Driving Value-Based Health Outcomes
Advanced Diabetes Supply Updated 10:41 AM CDT, Tue April 30, 2024 In today’s healthcare landscape, value-based outcomes are more than a trending topic; they’re a primary goal. And for individuals living with diabetes, value-based outcomes are the key to a healthy life. Diabetes management requires a comprehensive approach that includes medication and lifestyle adjustments as…
Read Next:
Diabetes, Products, Technology
Different Types of CGM: A Complete Guide
Blog, Diabetes, Products, Technology
What are Continuous Glucose Monitoring Devices and How to Choose a CGM?
Blog, Diabetes, Diet & Fitness
Just Diagnosed With Diabetes: A Guide
AHCA Licensure Numbers: 1313231 and 1314211
For Healthcare Professionals
Our Products
Insulin
Insulin Pen Needles & Syringes
US MED® is America's primary choice for home delivery of quality medical supplies. Since 1996, over 1 million satisfied members have received disease state education and medical supplies from our highly trained customer service specialists. US MED®, the largest provider of Diabetic Supplies to the Medicare community, is licensed and accredited by Accreditation Commission for Health Care (ACHC) and maintains an A+ rating from the Better Business Bureau. We provide all products necessary to treat the Diabetes disease state, including therapies for its associated comorbidities. Our product portfolio includes, but is not limited to, the following: Diabetic testing strips, Continuous Glucose Monitors or CGMs, Insulin Pumps, Sleep Apnea and CPAP supplies, and Nebulizers.